Ispronicline: A novel a4B2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties

P Lippiello; Sharon Letchworth; Gregory Gatto; V Traina; Merouane Bencherif

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Ispronicline: A novel a4B2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties

Lippiello, P., Letchworth, S., Gatto, G., Traina, V., & Bencherif, M. (2006). Ispronicline: A novel a4B2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties. Journal of Molecular Neuroscience, 30(1-2), 19 - 20.

Copy citation

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders

Ispronicline: A novel a4B2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties

Publications Info

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders

Article

"Show Me the Energy Costs"

Article

A new approach to a legacy concern

Chapter

Finding a way to survive